Bymaster FP, et al: Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 27: 699-711, 2002.
Newcorn JH, et al: Atomoxetine/Methylphenidate Comparative Study Group: Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response. Am J Psychiatry 165: 721-730, 2008.
杉山登志郎: 子ども虐待という第4の発達障害. 学研. 2007.
西澤 哲: 子ども虐待がそだちにもたらすもの. そだちの科学2: 10-16, 2004.
Hah M, Chang K: Atomoxetine for the treatment of attention deficit/hyperactivity disorder in children and adolescents with bipolar disorders. J Child Adoles Psychophalmacology 15: 966-1004, 2005.